Cannabis Bioscience International Holdings, Inc. (CBIH)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Jun 15, 2026, 10:08 AM EST
CBIH Revenue
Cannabis Bioscience International Holdings had revenue of $11.21K in the quarter ending February 28, 2026, a decrease of -24.95%. This brings the company's revenue in the last twelve months to $123.63K, down -64.05% year-over-year. In the fiscal year ending May 31, 2025, Cannabis Bioscience International Holdings had annual revenue of $303.02K with 21.77% growth.
Revenue (ttm)
123.63K
Revenue Growth
-64.05%
P/S Ratio
28.46
Revenue / Employee
61.81K
Employees
2
Market Cap
3.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 303.02K | 54.18K | 21.77% |
| May 31, 2024 | 248.84K | -67.98K | -21.46% |
| May 31, 2023 | 316.83K | 101.85K | 47.37% |
| May 31, 2022 | 214.98K | -546.76K | -71.78% |
| May 31, 2021 | 761.74K | 471.50K | 162.46% |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CV Sciences | 13.38M |
| Pure Harvest Corporate Group | 2.48M |
| SOHM, Inc. | 1.30M |
| For The Earth | 687.89K |
| Rafarma Pharmaceuticals | 133.33K |
| Indo Global Exchange(s) PTE | 3.49K |
Cannabis Bioscience International Holdings News
- 17 hours ago - CBIH Announces Patent-Related Scientific Framework for PTSD-Focused Cannabinoid and Psilocybin Research - Newsfile Corp
- 7 days ago - CBIH Advances Strategic Pathway to Bring VitaCookies' Science-Driven Functional Wellness Platform to Texas Consumers - Newsfile Corp
- 5 months ago - CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz's Team and an "Evidence Sprint 2026" Focused on Grants, Research and Clinical Evidence - Newsfile Corp
- 5 months ago - CBIH Launches Federal and Pharmaceutical Outreach Initiative to Accelerate Medical Cannabis Research in the Schedule III Transition - Newsfile Corp
- 6 months ago - CBIH Announces New Patent Initiative Targeting Opioid Addiction Through Endocannabinoid Pathways - Newsfile Corp
- 6 months ago - CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities - Newsfile Corp
- 8 months ago - CBIH Announces Women-First Fertility Innovation Built on Nanoemulsion Delivery - Newsfile Corp
- 9 months ago - CBIH Ignites Texas: Statewide TCUP Seminar Marks a New Era for Medical Cannabis-With Evidence, Safety, and Patient Dignity at the Center - Newsfile Corp